文献速递类风湿关节炎系统性红斑狼疮其他结缔组织病

PROMIS-29 在类风湿关节炎、骨关节炎、纤维肌痛和系统性红斑狼疮中的表现

Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus.
PubMed 文献 · Arthritis Care Res (Hoboken) · 2017-08-08

该研究基于美国风湿病数据库,评估 PROMIS-29 在类风湿关节炎、骨关节炎、纤维肌痛和系统性红斑狼疮患者中的测量性能。结果显示 PROMIS-29 静态简表可区分健康水平并与传统问卷测量相似构念,但部分量表存在明显天花板效应,且不同施测方式得分存在差异,支持使用需谨慎。

要点

  • PROMIS-29 在 RA、OA、SLE 中与传统量表相关性为中至高,FM 部分量表相关性明显较低。
  • 部分 PROMIS-29 量表出现明显天花板效应,可能限制反应度。
  • 在线与纸质问卷得分差异为 0.3 至 2.2 分。

核心结论

  • 结果对在这些疾病中使用 PROMIS-29 提供有保留的支持。
  • PROMIS-29 四条目静态表可识别健康水平差异并测量与传统问卷相似的构念。
  • 明显天花板效应提示测量在量表较差端可能更精确,可能限制反应度。
  • 不同施测方式之间似乎存在得分差异。

研究设计与样本

  • 研究纳入美国风湿病数据库参与者,完成 PROMIS-29(7 个领域各 4 条目)。
  • 样本量:类风湿关节炎 4346 例,骨关节炎 727 例,纤维肌痛 241 例,系统性红斑狼疮 240 例。
  • 参与者以女性为主,平均病程≥20 年,年龄约 60 岁。
  • 分析包括量表得分分布、聚合效度与已知组效度检验,以及在线与纸质问卷得分差异比较。

主要发现

  • 部分 PROMIS-29 量表出现大天花板效应。
  • PROMIS-29 得分与测量相似构念的量表相关性在 RA、OA、SLE 中为中至高,FM 部分量表相关性明显较低。
  • 随疾病严重度增加或健康状况下降,PROMIS-29 得分呈现一致的恶化模式。
  • 在线与纸质问卷所得得分差异范围为 0.3 至 2.2 分。

关键数值与推荐

  • PROMIS-29 包含 7 个 PROMIS 领域,每个领域 4 条目。
  • 量表得分转换为 T 分数。
  • 在线与纸质问卷得分差异为 0.3 至 2.2 分。

临床怎么用

  • 在 RA、OA、SLE 中可谨慎使用 PROMIS-29 评估患者报告结局,但需注意部分量表天花板效应可能影响反应度。
  • 在 FM 中使用 PROMIS-29 时,部分量表与传统问卷相关性较低,解读需谨慎。
  • 不同施测方式(在线 vs 纸质)可能带来得分差异,临床比较时应考虑施测方式一致性。

局限性

  • 部分 PROMIS-29 量表存在大天花板效应,可能限制反应度。
  • 不同施测方式之间存在得分差异。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: The Patient-Reported Outcomes Measurement Information System (PROMIS) was developed to improve measurement of patient-reported outcomes. We examined performance of the 29-item PROMIS Profile (PROMIS-29) in persons with rheumatoid arthritis (RA), osteoarthritis (OA), fibromyalgia (FM), and systemic lupus erythematosus (SLE). METHODS: Participants in the National Data Bank for Rheumatic Diseases completed the PROMIS-29, which includes 4-item forms for 7 PROMIS domains. Scales were scored and converted to T scores. Distributions of scale scores were examined, convergent and known-groups validity was tested, and differences in scores from online versus paper questionnaires were examined. RESULTS: Sample sizes were 4,346 for RA, 727 for OA, 241 for FM, and 240 for SLE. Participants were predominantly female, with a mean disease duration ≥20 years, and were ages ∼60 years. Large ceiling effects occurred for some PROMIS-29 scales. Correlations of PROMIS-29 scores with scales measuring similar constructs ranged from high to moderate for RA, OA, and SLE; correlations for FM were markedly lower for some scales. Consistent patterns of worsening PROMIS-29 scores with increasing disease severity or declining health status were observed. Differences in scores obtained by online versus paper questionnaires ranged from 0.3 to 2.2 points. CONCLUSION: Results provide guarded support for using the PROMIS-29 in these conditions. The PROMIS-29 4-item static forms appear to identify differences among levels of health and to measure constructs similar to those measured by legacy questionnaires. However, large ceiling effects suggest that measurement may be more precise at the "bad" ends of the scales, which may limit responsiveness, and differences by mode of administration appear to exist.

来源:Arthritis Care Res (Hoboken),查看原文。版权归原作者所有。

引用

  1. Katz P, Pedro S, Michaud K, et al. Performance of the Patient-Reported Outcomes Measurement Information System 29-Item Profile in Rheumatoid Arthritis, Osteoarthritis, Fibromyalgia, and Systemic Lupus Erythematosus. Arthritis Care Res (Hoboken). 2017. PMID: 28029753. doi:10.1002/acr.23183

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。